FOR IMMEDIATE RELEASE
MESA, Ariz. — November 18, 2025
Dr. Marchand’s Analysis of Self Collected Pap Smears is online today in AJOG’s “Global Reports.” The paper, “Patient vs. clinician-collected cervical cytology for screening for CIN: a systematic review and meta-analysis.” You can view the paper online open access through the publisher (Elsevier): 10.1016/j.xagr.2025.100575, or through the US Government’s NIH website: https://pmc.ncbi.nlm.nih.gov/articles/PMC12615280/.
About the Marchand Institute for Minimally Invasive Surgery
The Marchand Institute for Minimally Invasive Surgery is a 501(c)(3) tax-exempt non-profit research and educational institution based in Mesa, Arizona (EIN 42-2857240). The Institute produces peer-reviewed systematic reviews and meta-analyses in minimally invasive gynecologic surgery and women’s health, conducts FDA clinical trials, and trains surgeons through an SLS-accredited fellowship. All reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised using the Cochrane RoB 2 tool. The Institute accepts no pharmaceutical or medical device industry funding and declares no conflicts of interest. It is directed by Greg J. Marchand, MD, FACS, FACOG, FICS.
Media Contact
Maria A. Sainz, Director of Communications and Media Relations
Marchand Institute for Minimally Invasive Surgery
maria@marchandobgyn.com | (480) 999-0905
Interview requests, expert commentary topics, boilerplate and high-resolution images: Newsroom & Press Kit. Complete publication record with DOIs and PMIDs: Publications database. Methodology: How we run a review.
###